Connect with others who understand.

  • Learn from expert-reviewed resources
  • Real advice from people who’ve been there
  • People who understand what you’re going through
Sign Up Log In
Powered By
Real members of MyMyelomaTeam have posted questions and answers that support our community guidelines, and should not be taken as medical advice. Looking for the latest medically reviewed content by doctors and experts? Visit our resource section.

I'll be going through STR in May or June, hopefully and we want to be able to travel, etc. when I go into remission which will probably be next year. Thanks!

February 17
 · 
Reactions
A MyMyelomaTeam Member

Hi

When I first heard about maintenance therapy after stem cell transplant, I thought the hardest part would be over. Transplant done, remission coming — life can go back to normal, right?

But my doctor explained something important.

Transplant is like clearing the battlefield.
Maintenance is like keeping guard so the enemy doesn’t quietly return.

The most common guard is Revlimid. It’s a pill, usually taken 21 days out of 28. Many people like it because it’s convenient — especially if you want to travel. You just pack your medication and go.

The good part? It has strong data showing it can keep remission longer.

The not-so-good part? Some people experience fatigue, low blood counts, or need to take aspirin to prevent clots. But for many, it’s manageable.

For higher-risk patients, doctors sometimes use Velcade instead. That one is an injection — usually every couple of weeks. It’s powerful and helpful for certain genetic risks. But it means clinic visits, which can make long travel a bit more complicated.
( My MM high risk aggressive type)

Then there’s Darzalex, a newer option. Some doctors combine it with Revlimid for deeper remission. It can be monthly injections after the first phase. It’s promising, but it also means scheduling around appointments.

So the real question becomes:
What balance do you want between protection and freedom?

Some people choose the simplest plan so they can travel and live fully. Others choose a stronger combination if their disease risk is higher.

Maintenance isn’t meant to feel like heavy chemo. It’s usually gentler. The goal is quiet control and staying in remission while living your life.

And yes , many people do travel during maintenance. They plan refills ahead, coordinate lab work, and stay in touch with their doctor.

Stem cell transplant is a big mountain.
Maintenance is the long road after the mountain — steady, watchful, but still full of life.

And remission? That’s not the end of living.
It’s the beginning of living more intentionally.

That’s a very important question — especially if you’re planning ahead for remission and hoping to travel after transplant. Planning early is smart.

After an autologous stem cell transplant (ASCT), maintenance therapy is commonly used to prolong remission and delay relapse.

Searching MM information is like you reading a newspaper every day ( old school times)

“For my experience not every MM patient had the same symptoms, side effects and other symptoms that you not expected “

🙏🌿
Moh

February 18
A MyMyelomaTeam Member

Thank you so much. Kind of what I expected recently but thus the question. I will share this with my husband as he may have some more questions.

February 18
MyMyelomaTeam

What are the common maintenance therapy options after stem cell transplant?

After a stem cell transplant, lenalidomide has become the most common maintenance therapy for myeloma. It's considered a standard of care because it's generally well-tolerated and helps keep myeloma in remission longer.

Other options include
- Show Full Answer

What are the common maintenance therapy options after stem cell transplant?

After a stem cell transplant, lenalidomide has become the most common maintenance therapy for myeloma. It's considered a standard of care because it's generally well-tolerated and helps keep myeloma in remission longer.

Other options include:
- Bortezomib or ixazomib (proteasome inhibitors) - sometimes used for people with certain high-risk genetic features
- Daratumumab (a monoclonal antibody) - occasionally used when myeloma returns after transplant
- Corticosteroids like dexamethasone or prednisone - often combined with other maintenance drugs

The specific choice depends on your individual situation, including your risk factors and how your body responds to treatment. What are the pros and cons of these maintenance therapies?

Lenalidomide pros:
- Well-tolerated by most people
- Taken by mouth at home, making travel more manageable
- Studies show it sustained remission for about 57 months in half of participants after transplant, compared to 30 months without maintenance
- May become more effective over time

Lenalidomide cons:
- Can cause changes in blood counts
- Increased risk of blood clots (aspirin or blood thinners may help)
- Possible side effects include bleeding problems, infections, anemia, and nerve damage

Other proteasome inhibitors:
- May be beneficial for high-risk disease
- Side effects vary by specific drug

Thalidomide:
- Now considered less favorable due to higher toxicity and risk of peripheral neuropathy (nerve damage)

Many people stay on maintenance therapy indefinitely as long as side effects remain manageable, since longer treatment often provides greater benefits. The good news is that maintenance drugs are taken at home, which should allow you to travel and maintain quality of life during remission.

February 17

Related Questions

View All
A MyMyelomaTeam Member asked a question 💭
Brownsville, TX

A MyMyelomaTeam Member asked a question 💭
Rawdon